• Join
  • Login
  • Contact

Search abstracts

Exploring innovative regulatory pathways: a US perspective

  • At: Stockholm (Sweden) (2017)
  • Type: Presentation
  • By: LIBERTI, Lawrence (CIRS, Holland, United States)
  • Co-author(s): Lawrence Liberti: CIRS, Holland, United States
  • Abstract:

    Pharmaceutical innovation results from the efficient partnership between drug developers, regulators, payers and patients among others stakeholders.   A regulatory agency, with the support of its legislature, can stimulate and support innovation through the active application of various elements of regulatory science. In the US, programmes have


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses